The role of the estrogen receptor in tumor progression

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 87-91

  Lemieux, Pierre ^a   Fuqua, Suzanne ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

BINDING SITE; BREAST CANCER; CONFERENCE PAPER; DELETION MUTANT; FEMALE; HUMAN; NONHUMAN; PROTEIN DOMAIN; PROTEIN VARIANT;

EID: 0030008295     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00269-3     Document Type: Conference Paper

References (21)

1. Trichopoulos D. B., MacMahon B. and Cole P.: Menopause and breast cancer risk. JNCI 48 (1972) 605-613.
2. Vessey M. P.: The involvement of oestrogen in the development and progression of breast disease: epidemiological evidence. Proc. R. Soc. Edinb. 95B (1989) 35.
3. Henderson B. E., Ross R. and Berstein L.: Estrogens as a cause of human cancer. Cancer Res. 48 (1988) 246-253.
4. Wolff M. S., Toniolo P. G., Lee E. N., Rivera M. and Dubin N.: Blood levels of organochlorine residues and risk of breast cancer. JNCI 85 (1993) 648-652.
5. Roberts M., Wallace J., Jeltsch J. M., and Berry M.: The 5′ flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells. Biochem. Biophys. Res. Commun. 151 (1988) 306-313.
6. Clarke C. L.: Cell-specific regulation of progesterone receptor in the female reproductive system. Molec. Cell Endocr. 70 (1990) C29-33.
7. Kumar V., Green S., Stack G., Berry M., Jin J. R. and Chambon P.: Functional domains of the human estrogen receptor. Cell 51 (1987) 941-951.
8. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E. and Chambon P.: The human estrogen receptor has two independent non-acidic transcriptional activation functions. Cell 59 (1989) 477-487.
9. Osborne C. K., Yochomowitz M. G., Knight W. A. and McGuire W. L.: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46 (1980) 2884-2888.
10. Ricketts D., Turnbull L., Ryall G., Bakhshi R., Rawson N. S. B., Gazet J.-C., Nolan C. and Coombes R. C.: Estrogen and progesterone receptors in the normal female breast. Cancer Res. 51 (1991) 1817-1822.
11. Fuqua S. A. W., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W. and McGuire W. L.: A variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51 (1991) 105-109.
12. Allegra J. C., Lippman M. E. and Green L.: Estrogen receptor values in patients with benign breast disease. Cancer 44 (1979) 228-231.
13. van Agthoven T., Timmermans M., Foekens J. A. and Dorssers L. C. J., Henzen-Logmans S. C.: Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am. J. Path. 144 (1994) 1238-1246.
14. Sadovsky Y., Webb P., Lopez G., Baxter J. D., Fitzpatrick P. M., Gizang-Ginsberg E., Cavailles V., Parker M. G. and Kushner P. J.: Transcriptional activators differ in their responses to overexpression of TATA-box-binding-protein. Molec. Cell Biol. 15 (1995) 1554-1563.
15. Zawel L. and Reinberg D.: Initiation of transcription by RNA polymerase II: a multi-step process. Prog. Nucl. Acid Res. Molec. Biol. 44 (1993) 69-108.
16. Landel C. C., Kushner P. J. and Greene G. L.: The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Molec. Endocr. 8 (1994) 1407-1419.
17. Cavaillès V., Dauvois S., Danielian P. S. and Parker M. G.: Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natn. Acad. Sci. 91 (1994) 10,009-10,013.
18. Halachmi S., Marden E., Martin G., Mackay H., Abbondanza C. and Brown M.: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458.
19. Baniahmad C., Nawaz Z., Baniahmad A., Gleeson M. A., Tsai M-J. and O'Malley B. W.: Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Molec. Endocr. 9 (1995) 34-43.
20. McDonnell D. P., Vegeto E. and O'Malley B. W.: Indentification of a negative regulatory function for steriod receptors. Proc. Natn. Acad. Sci. 89 (1992) 10,563-10,567.
21. Le Douarin B., Zechel C., Garnier J-M., Lutz Y., Tora L., Pierrat B., Heery D., Gronemeyer H., Chambon P. and Losson R.: The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO 14 (1995) 2020-2033.